*Articles from the former Asklep
Asklep Inc. has spun off its clinical development operation and the related businesses to A2 Healthcare Corporation effective June 2nd, 2014.
We are committed to concentrating our management resources in the field of medical intelligence and thus in line with the core value of Asklep of creating and providing highly valuable medical intelligence.
We are the “Medical Intelligence Provider” in Japan.
Striving to be a high value-added intelligence provider
We continue to be the sole entity that creates and offers high value-added medical intelligence,
which enables us to further optimize the Quality of Life for patients and societies around the world.
Newly-appointed Asklep Executive Officers
|Name||New Role||Previous Role|
Director of the Sales & Marketing Division
Director of the Medical Intelligence Division
|Deputy Director of the Medical Intelligence Division|
|Shinya Ohshima||Director; Special Mission,|
Quality Assurance and Medical Writer
|Itaru Nango||Unchanged||Part-time Outside Director;|
Executive Director, INTAGE HOLDINGS Inc.
|Susumu Matsumoto||Unchanged||Part-time Outside Director; |
Director, INTAGE HOLDINGS Inc.
|Tohru Sakamoto||Unchanged||Part-time Outside Corporate Auditor; Corporate Auditor, INTAGE HOLDINGS Inc.|
|Tadazumi Matsuura||Operating Officer; Director of the Corporate Planning and Development Division||Corporate Planning Director, Corporate Planning and Development Division|